Detail
LncRNA Name | ZEB1-AS1 |
Synonyms | NR_024284 |
Region | GRCh38_10:31206278-31320447 Sequence |
Ensembl | ENSG00000237036 |
RefSeq | NR_024284 |
Circulating | ✘ |
Drug-resisitant | ✘ |
Prognostic | ✔ |
MiRNA | ✘ |
Variant | ✘ |
TF | ✘ |
Methylation | ✘ |
Cancer Name | osteosarcoma |
ICD-0-3 | M9180/3 |
Methods | qPCR, RNAi, Western blot, RIP, ChIP, Cell proliferation assay etc. |
Sample | osteosarcoma tissues, cell lines (hFOB 1.19, HOS, U-2 OS, MG-63, and Saos-2) |
Expression Pattern | up-regulated |
Function Description | The results showed that ZEB1-AS1 was upregulated in osteosarcoma tissues and cells. Increased expression of ZEB1-AS1 is correlated with larger tumor size, progressed Enneking stage, tumor metastasis, worse recurrence-free and overall survival of osteosarcoma patients. Functional experiments showed that enhanced expression of ZEB1-AS1 promotes osteosarcoma cells proliferation and migration. By contrast, ZEB1-AS1 knockdown inhibits osteosarcoma cells proliferation and migration. Mechanistically, ZEB1-AS1 directly binds and recruits p300 to the ZEB1 promoter region, induces an open chromatin structure, and activates ZEB1 transcription. |
Pubmed ID | 27829995 |
Year | 2016 |
Title | Long noncoding RNA ZEB1-AS1 acts as an oncogene in osteosarcoma by epigenetically activating ZEB1. |
External Links |
Links for ZEB1-AS1 | GenBank HGNC lncrnadb Noncode |
Links for osteosarcoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.